As of 2024-12-12, the Relative Valuation of RELIEF THERAPEUTICS Holding SA (RLF.SW) is (52.27) CHF. This relative valuation is based on P/E multiples. With the latest stock price at 3.73 CHF, the upside of RELIEF THERAPEUTICS Holding SA based on Relative Valuation is -1501.2%.
The range of the Relative Valuation is (56.49) - (58.92) CHF.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 16.0x | 15.6x |
| Forward P/E multiples | 8.2x - 17.2x | 12.7x |
| Fair Price | (56.49) - (58.92) | (52.27) |
| Upside | -1614.4% - -1679.7% | -1501.2% |
| Date | P/E |
| 2024-11-25 | -1.37 |
| 2024-11-22 | -1.36 |
| 2024-11-21 | -1.44 |
| 2024-11-20 | -1.45 |
| 2024-11-19 | -1.25 |
| 2024-11-18 | -1.36 |
| 2024-11-15 | -1.65 |
| 2024-11-14 | -1.79 |
| 2024-11-13 | -1.76 |
| 2024-11-12 | -1.75 |
| 2024-11-11 | -1.80 |
| 2024-11-08 | -1.58 |
| 2024-11-07 | -1.58 |
| 2024-11-06 | -1.55 |
| 2024-11-05 | -1.65 |
| 2024-11-04 | -1.65 |
| 2024-11-01 | -1.65 |
| 2024-10-31 | -1.55 |
| 2024-10-30 | -1.58 |
| 2024-10-29 | -1.63 |
| 2024-10-28 | -1.73 |
| 2024-10-25 | -1.72 |
| 2024-10-24 | -1.62 |
| 2024-10-23 | -1.53 |
| 2024-10-22 | -1.55 |
| 2024-10-21 | -1.65 |
| 2024-10-18 | -1.43 |
| 2024-10-17 | -1.41 |
| 2024-10-16 | -1.48 |
| 2024-10-15 | -1.55 |
| 2024-10-14 | -1.44 |
| 2024-10-11 | -1.17 |
| 2024-10-10 | -1.49 |
| 2024-10-09 | -1.72 |
| 2024-10-08 | -1.12 |
| 2024-10-07 | -0.80 |
| 2024-10-04 | -0.75 |
| 2024-10-03 | -0.65 |
| 2024-10-02 | -0.65 |
| 2024-10-01 | -0.66 |
| 2024-09-30 | -0.69 |
| 2024-09-27 | -0.70 |
| 2024-09-26 | -0.73 |
| 2024-09-25 | -0.71 |
| 2024-09-24 | -0.66 |
| 2024-09-23 | -0.71 |
| 2024-09-20 | -0.63 |
| 2024-09-19 | -0.56 |
| 2024-09-18 | -0.61 |
| 2024-09-17 | -0.56 |